{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:59:16Z","timestamp":1790189956652,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:p>Liver damage, ranging from mild hepatic impairment to severe liver failure, presents a significant global health burden with limited therapeutic options. Understanding the molecular underpinnings of liver damage and identifying actionable protein targets are crucial for advancing treatment strategies. We employed summary-data-based Mendelian randomization and colocalization analyses to identify plasma proteins associated with 6 liver biomarkers (aspartate transaminase, alanine transaminase, alkaline phosphatase, gamma-glutamyltransferase, total bilirubin, and direct bilirubin) by leveraging proteomic data from the deCODE cohort. Functional enrichment analyses were conducted to elucidate biological roles, and protein\u2013protein interaction networks were constructed to explore their relationship with current drug targets for liver damage drug prediction and molecular docking studies were performed to evaluate therapeutic potential and drug\u2013target interactions. In the summary-data-based Mendelian randomization analysis, while 21 to 106 proteins were found to be significant, only 30 were validated as potential drug targets through colocalization analysis (PP.H4\u2005&gt;\u20050.8). Enrichment analysis shows involvement in purine metabolism, nucleotide metabolism, and other pathways. Protein\u2013protein interaction networks identified interactions with known liver damage pathways. Drug prediction highlighted potential compounds, including 7,8-benzoflavone, quercetin and tetradioxin, with strong binding affinities validated by molecular docking. This integrative study identified 30 proteins with strong evidence as potential therapeutic targets for liver damage. We provide novel insights into the molecular mechanisms of liver damage and actionable leads for drug development. Further functional and clinical validation is warranted to translate these findings into personalized therapeutic strategies.<\/jats:p>","DOI":"10.1097\/md.0000000000044628","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:00:15Z","timestamp":1757970015000},"page":"e44628","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Revealing potential drug targets in liver dysfunction through proteome-wide Mendelian randomization"],"prefix":"10.1097","volume":"104","author":[{"given":"Xin-Mei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Xin","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ting","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Dong","family":"Xia","sequence":"additional","affiliation":[{"name":"Health Management Center, The Affiliated Hospital of Southwest Medical University, Luzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis.","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet (London)"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(24)00693-7","article-title":"Acute liver failure.","volume":"404","author":"Maiwall","year":"2024","journal-title":"Lancet (London)"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMc2023198","article-title":"Acute-on-chronic liver failure.","volume":"383","year":"2020","journal-title":"N Engl J Med"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions.","volume":"21","author":"Mak","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets.","volume":"16","author":"Santos","year":"2016","journal-title":"Nat Rev Drug Discovery"},{"key":"R6-20260923","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aaq1327","article-title":"Co-regulatory networks of human serum proteins link genetics to disease.","volume":"361","author":"Emilsson","year":"2018","journal-title":"Science"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0050177","article-title":"Mendelian randomisation and causal inference in observational epidemiology.","volume":"5","author":"Sheehan","year":"2008","journal-title":"PLoS Med"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat Genet"},{"key":"R9-20260923","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease.","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"key":"R10-20260923","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41588-021-00892-1","article-title":"Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses.","volume":"53","author":"Barton","year":"2021","journal-title":"Nat Genet"},{"key":"R11-20260923","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"key":"R12-20260923","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics.","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"key":"R13-20260923","doi-asserted-by":"crossref","first-page":"D1353","DOI":"10.1093\/nar\/gkac1046","article-title":"The next-generation open targets platform: reimagined, redesigned, rebuilt.","volume":"51","author":"Ochoa","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"R14-20260923","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest.","volume":"51","author":"Szklarczyk","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"R15-20260923","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","article-title":"DSigDB: drug signatures database for gene set analysis: Fig. 1.","volume":"31","author":"Yoo","year":"2015","journal-title":"Bioinformatics"},{"key":"R16-20260923","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","article-title":"PubChem BioAssay: 2017 update.","volume":"45","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R17-20260923","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471250953.bi0814s24","article-title":"Using AutoDock for ligand\u2013receptor docking.","volume":"24","author":"Morris","year":"2008","journal-title":"Curr Protoc Bioinformatics"},{"key":"R18-20260923","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2015.12.018","article-title":"The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14).","volume":"104","author":"Herro","year":"2016","journal-title":"Pharmacol Res"},{"key":"R19-20260923","doi-asserted-by":"crossref","first-page":"101989","DOI":"10.1016\/j.molmet.2024.101989","article-title":"Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis.","volume":"87","author":"Ruiz-Bl\u00e1zquez","year":"2024","journal-title":"Mol Metab"},{"key":"R20-20260923","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/gut.2006.092460","article-title":"Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats.","volume":"56","author":"Kinoshita","year":"2006","journal-title":"Gut"},{"key":"R21-20260923","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmet.2019.08.008","article-title":"miR-873-5p targets mitochondrial GNMT-complex II interface contributing to non-alcoholic fatty liver disease.","volume":"29","author":"Fern\u00e1ndez-Tussy","year":"2019","journal-title":"Mol Metab"},{"key":"R22-20260923","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7150\/ijms.5765","article-title":"The anti-fibrotic effect of bone morphogenic protein-7 (BMP-7) on liver fibrosis.","volume":"10","author":"Zhong","year":"2013","journal-title":"Int J Med Sci"},{"key":"R23-20260923","first-page":"763","article-title":"A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor-\u03b2 signaling.","volume":"12","author":"Cho","year":"2022","journal-title":"Am J Cancer Res"},{"key":"R24-20260923","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/hep.23639","article-title":"Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.","volume":"52","author":"Varela\u2010Rey","year":"2010","journal-title":"Hepatology"},{"key":"R25-20260923","doi-asserted-by":"crossref","first-page":"11814","DOI":"10.1038\/s41598-024-62742-4","article-title":"Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"R26-20260923","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/imr.13205","article-title":"Modulation of immunity by the secreted phospholipase A2 family.","volume":"317","author":"Murakami","year":"2023","journal-title":"Immunol Rev"},{"key":"R27-20260923","doi-asserted-by":"crossref","first-page":"e87523","DOI":"10.1371\/journal.pone.0087523","article-title":"Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.","volume":"9","author":"Petta","year":"2014","journal-title":"PLoS One"},{"key":"R28-20260923","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12944-025-02515-8","article-title":"Druggable genome-wide Mendelian randomization identifies therapeutic targets for metabolic dysfunction-associated steatotic liver disease.","volume":"24","author":"Ma","year":"2025","journal-title":"Lipids Health Dis"},{"key":"R29-20260923","doi-asserted-by":"crossref","first-page":"1512470","DOI":"10.3389\/fimmu.2024.1512470","article-title":"Complement activation drives the phagocytosis of necrotic cell debris and resolution of liver injury.","volume":"15","author":"Vandendriessche","year":"2024","journal-title":"Front Immunol"},{"key":"R30-20260923","doi-asserted-by":"crossref","first-page":"117248","DOI":"10.1016\/j.cca.2023.117248","article-title":"Roles and correlations of TIM-3 and LAG-3 with cytokines and chemokines in alcoholic liver disease.","volume":"541","author":"Fadriquela","year":"2023","journal-title":"Clin Chim Acta"},{"key":"R31-20260923","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12865-019-0309-9","article-title":"CD4+ T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B.","volume":"20","author":"Dong","year":"2019","journal-title":"BMC Immunol"},{"key":"R32-20260923","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.yexcr.2017.07.008","article-title":"AMPK activation ameliorates d-GalN\/LPS-induced acute liver failure by upregulating Foxo3A to induce autophagy.","volume":"358","author":"Liu","year":"2017","journal-title":"Exp Cell Res"},{"key":"R33-20260923","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12916-021-01917-6","article-title":"Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases.","volume":"19","author":"Guldiken","year":"2021","journal-title":"BMC Med"},{"key":"R34-20260923","doi-asserted-by":"crossref","first-page":"28884","DOI":"10.1038\/s41598-024-80483-2","article-title":"Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome.","volume":"14","author":"Xiao","year":"2024","journal-title":"Sci Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:00:42Z","timestamp":1790186442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":34,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044628","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"2025-05-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}